• Compass Therapeutics to Present at Upcoming Investment Conferences

    المصدر: Nasdaq GlobeNewswire / 08 نوفمبر 2022 08:00:01   America/New_York

    BOSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today announced it will be presenting at the following investor conferences during the month of November 2022.

    Presentation details are as follows:

    Stifel Healthcare Conference in New York City
    Date: Tuesday, November 15, 2022
    Time: 4:10-4:40 PM ET
    Webcast Link: https://wsw.com/webcast/stifel74/cmpx/2109872

    Jefferies Global Healthcare Conference in London, UK
    Date: Wednesday, November 16, 2022
    Time: 3:15 – 3:45 PM GMT
    Webcast Link: https://wsw.com/webcast/jeff255/cmpx/1866024

    Virtual/Replay availability: The corporate presentation will be archived for 90 days on Compass’ Events page.

    About Compass Therapeutics

    Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com.

    Investor Contact
    Mario Corso, Executive Director and Head of Investor Relations
    ir@compasstherapeutics.com

    Media Contact
    Anna Gifford, Communications Manager
    media@compasstherapeutics.com
    617-500-8099


    Primary Logo

شارك على،